Recently, Wolk at al. reported that the expression of granulocyte colony-stimulating factor (G-CSF), a key regulator of neutrophil survival and function, resulted in an incremented in both the skin lesions and blood of HS patients. This evidence concerns the gene CSF3 and histiocytic sarcoma.